Department of Intensive Care Unit, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China 325015.
Transplantation centre, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China 325015.
Int J Med Sci. 2018 Sep 7;15(13):1433-1442. doi: 10.7150/ijms.26954. eCollection 2018.
Renal tubule cell apoptosis plays a pivotal role in the progression of chronic renal diseases. The previous study indicates that Sirolimus is effective on unilateral ureteral obstruction (UUO)-induced renal fibrosis. However, the role of Sirolimus in renal tubular apoptosis induced by UUO has not yet been addressed. The aim of this study was to determine the role of Sirolimus in renal tubular apoptosis induced by UUO. Male Sprague-Dawley rats were divided into three groups, sham-operated rats, and after which unilateral ureteral obstruction (UUO) was performed: non-treated and sirolimus-treated (1mg/kg). After 4, 7 and 14 d, animals were sacrificed and blood, kidney tissue samples were collected for analyses. Histologic changes and interstitial collagen were determined microscopically following HE and Masson's trichrome staining. The expression of PCNA was investigated using immunohistochemistry and the expression of Bcl-2, Bax, caspase-9, and caspase-3 were investigated using Western blot in each group. Tubular apoptotic cell deaths were assessed by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay. Sirolimus administration resulted in a significant reduction in tubulointerstitial fibrosis scores. After UUO, there was an increase in tubular and interstitial apoptosis in untreated controls as compared to Sirolimus treatment rats (<0.05). In addition, the expression of PCNA, Bcl-2, Bax, caspase-9, and caspase-3 in obstructed kidney was characterized by immunohistochemistry and Western blot analyses demonstrating that sirolimus treatment significantly reduced PCNA, Bax, caspase-9 and cleaved caspase-3 expression compared to those observed in controls (<0.05), whereas, Bcl-2 in the obstructed kidney were decreased in untreated controls compared to Sirolimus treatment rats subjected to the same time course of obstruction (<0.05). We demonstrated a marked renoprotective effect of sirolimus by inhibition of UUO-induced renal tubular apoptosis in vivo.
肾小管细胞凋亡在慢性肾脏病的进展中起着关键作用。先前的研究表明,西罗莫司对单侧输尿管梗阻(UUO)诱导的肾纤维化有效。然而,西罗莫司在 UUO 诱导的肾小管凋亡中的作用尚未得到解决。本研究旨在确定西罗莫司在 UUO 诱导的肾小管凋亡中的作用。雄性 Sprague-Dawley 大鼠分为三组:假手术组和单侧输尿管梗阻(UUO)后:未治疗和西罗莫司治疗(1mg/kg)。4、7 和 14d 后,处死动物并采集血液和肾脏组织样本进行分析。通过 HE 和 Masson 三色染色显微镜下观察组织学变化和间质胶原。用免疫组化法检测 PCNA 的表达,用 Western blot 法检测各组中 Bcl-2、Bax、caspase-9 和 caspase-3 的表达。通过末端脱氧核苷酸转移酶介导的 dUTP 缺口末端标记(TUNEL)测定评估肾小管细胞凋亡。西罗莫司给药导致肾小管间质纤维化评分显著降低。UUO 后,未治疗对照组肾小管和间质凋亡增加,而西罗莫司治疗组大鼠则减少(<0.05)。此外,PCNA、Bcl-2、Bax、caspase-9 和 caspase-3 的表达通过免疫组化和 Western blot 分析来描述,结果表明,与对照组相比,西罗莫司治疗组明显降低了 PCNA、Bax、caspase-9 和裂解 caspase-3 的表达(<0.05),而在未治疗对照组中,Bcl-2 在梗阻性肾脏中的表达较西罗莫司治疗组在相同时间点的梗阻大鼠中减少(<0.05)。我们在体内证明了西罗莫司通过抑制 UUO 诱导的肾小管凋亡具有明显的肾脏保护作用。